Kolmar Holdings' business can be defined as the "Star Business Model," encompassing daily lifestyle products along with cosmetics, Pharmaceutical and Bio-Pharma, and health supplements to promote health. We focus our every effort on our clients and create technology-centered values for the beauty and health of all humankind.
Kolmar Korea was the first to introduce the ODM process in the Korean cosmetic industry. Based on our exceptional technology and high product quality, we provide a systematic, complete service ranging from trend analysis, product planning, and development to shipments and management processes. We support brands so that K-Beauty will continue to expand throughout the world.
HK inno.N is Korea's leading pharmaceutical company, combining the Fourth Industrial Revolution technologies with biopharmaceuticals to create innovations in advanced bio and healthcare fields. We invest our research capabilities in developing new drugs to treat liver, cancer, immunological disorders, infections, and vaccines. The 'K-CAB Tab.', Korea‘s 30th new drug launched in 2019, is rewriting the history of new blockbuster medicines.
Kolmar BNH is the first public-private joint venture established by Kolmar Korea and the Korea Atomic Energy Research Institute. It is the first research institute to be registered with the Ministry of Science, ICT, and Future Planning. We are the lead innovators of the Korean health supplement market by researching and developing new materials derived from natural substances.